Early treatment with noradrenaline for shock in emergency departments
Official title: Early Initiated Vasopressor Therapy vs. Standard Care of Primarily Fluid Therapy in Hypotensive Patients in the Emergency Department - A Pragmatic, Multi-center, Superiority, Randomized Controlled Trial
Run by Odense University Hospital · NCT05931601 · Data updated 2026-11-12
This study tests if giving noradrenaline right away helps people in shock feel better and recover faster than just using standard fluids.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 320 (estimated) |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 8 sites (Copenhagen and 7 other locations) |
| Status | Recruiting |
| Started | December 8, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | July 1, 2025 |
| Trial ID | NCT05931601 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older presenting with signs of hypotension or shock who have received at least 500ml of intravenous fluid within the first 4 hours of emergency department arrival.
✕Probably not a fit
Patients with a Clinical Frailty Score of 5 or higher who are not suitable for ICU admission may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of early initiated peripheral infusion of noradrenaline compared to standard fluid therapy in patients experiencing hypotension and shock in Danish Emergency Departments. It is a pragmatic, multi-center, superiority, randomized trial that will assess outcomes such as time to shock control, ICU admission rates, and mortality. Participants will receive either noradrenaline or usual treatment urgently upon presentation, and their health data will be collected for analysis. Follow-up will occur one year after treatment to gather additional patient-reported outcomes.
Why it matters
Potential benefit: If successful, this approach could lead to improved management of hypotensive patients, potentially reducing mortality and ICU admissions.
How similar studies have gone: Other studies have shown promising results with early vasopressor therapy in similar contexts, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years of age * Signs or suspicion of hypotension or shock (of any type such as septic, vasodilatory or hypovolemic not included in the exclusion criteria) defined as: 1. SBP \< 100mmHg or MAP \< 65 mmHg combined with lactate \> 2.0 mmol/L, 2. Physician defined blood pressure for the individual patient combined with a lactate \> 2.0 mmol/L 3. Either SBP \< 100mmHg or MAP \< 65mmHg with obvious signs of shock with any lactate level evaluated by either two non-specialist physicians (e.g. registrar medical doctors) or a specialist physician. * Received at least 500ml of intravenous fluid before study inclusion (Including prehospital administration) within the first 4 hours of ED arrival. * Clinical Frailty Score (CFS) of ≤4. If CFS is ≥5 and the treating physician find the patient suitable for ICU admittance, the participant can be enrolled, if the on-call ICU doctor would accept the patient for ICU admittance. If the treating physician is unsure of ICU eligibility, regardless of CFS score, the patient should be consulted with the ICU consultant before study inclusion. Exclusion Criteria: * Cardiogenic, anaphylactic, haemorrhagic, or neurogenic shock suspected by the treating physician. * Fertile women (\<60 years of age) with positive urine human gonadotropin (hCG) or plasma-hCG or women breastfeeding. * Patient deemed terminally ill or with a severe co-morbid status resulting in non-eligibility for ICU admittance decided by either the treating physician or ICU consultant. * Known allergy to noradrenaline.
Where it's running
-
Bispebjerg Hospital
Copenhagen, Denmark Recruiting -
Zealand University Hospital
Køge, Denmark Recruiting -
Odense University Hospital
Odense, Denmark Recruiting -
Esbjerg Hospital
Esbjerg, Denmark Terminated -
Gødstrup Regional Hospital
Herning, Denmark Not yet recruiting -
Department of Emergency Medicine
Helsingborg, Sweden Not yet recruiting
Show 2 more locations
-
Department of Emergency Medicine
Linköping, Sweden Not yet recruiting -
Department of Emergency Medicine
Ystad, Sweden Not yet recruiting
Study contacts
- Principal investigator: Lasse P Bentsen, MD — Department of Emergency Medicine, Odense University Hospital
- Study coordinator: Lasse P Bentsen, MD
- Email: lasse.paludan.bentsen@rsyd.dk
- Phone: +4520496950
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulse palpation vs arterial blood pressure in circulatory shock
This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.
-
Using a glucose measurement system in intensive care for patients with shock
This study is testing a new glucose monitoring system to see if it can help make checking blood sugar easier and more comfortable for patients in intensive care who are dealing with septic shock.
-
Cardiac Arrest: Using Ultrasound to Find Hidden Blood Flow
This study tests whether patients who have out-of-hospital cardiac arrest but no pulse still show some blood flow on ultrasound and whether that finding relates to survival.
-
Gastric emptying and feeding tolerance in ICU patients by vasopressor dose
This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.
-
Perfusion Index as a Predictor of Spinal Anesthesia–Induced Hypotension in Day-Case Knee Arthroscopy
This study looks to see if a baseline perfusion index can predict low blood pressure after spinal anesthesia in healthy adults having knee arthroscopy.
-
Argos system to track cardiac output changes in critically ill patients
This study tests whether the Argos monitor can reliably track how cardiac output changes after fluid administration or norepinephrine adjustments in critically ill adults already monitored with transpulmonary thermodilution.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.